Idexx Laboratories (IDXX) Income from Continuing Operations: 2009-2024
Historic Income from Continuing Operations for Idexx Laboratories (IDXX) over the last 16 years, with Dec 2024 value amounting to $887.9 million.
- Idexx Laboratories' Income from Continuing Operations rose 17.94% to $274.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.0 billion, marking a year-over-year increase of 18.61%. This contributed to the annual value of $887.9 million for FY2024, which is 5.07% up from last year.
- Per Idexx Laboratories' latest filing, its Income from Continuing Operations stood at $887.9 million for FY2024, which was up 5.07% from $845.0 million recorded in FY2023.
- Over the past 5 years, Idexx Laboratories' Income from Continuing Operations peaked at $887.9 million during FY2024, and registered a low of $582.1 million during FY2020.
- In the last 3 years, Idexx Laboratories' Income from Continuing Operations had a median value of $845.0 million in 2023 and averaged $804.0 million.
- Per our database at Business Quant, Idexx Laboratories' Income from Continuing Operations spiked by 36.08% in 2020 and then fell by 8.83% in 2022.
- Over the past 5 years, Idexx Laboratories' Income from Continuing Operations (Yearly) stood at $582.1 million in 2020, then climbed by 27.95% to $744.8 million in 2021, then fell by 8.83% to $679.1 million in 2022, then increased by 24.44% to $845.0 million in 2023, then grew by 5.07% to $887.9 million in 2024.